Age: 63.0
Sex: F
Vaccine: UNK
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: The patient had very painful swollen glands in her throat/sore throat; I developed symptoms, testing positive two days later. My symptoms have been significantly worse that his; The next day the patient got head and chest congestion. Felt like I had bronchitis; I was coughing; Painful Swollen glands; Patient reports that she had a sore left arm at the site of the injection; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (I developed symptoms, testing positive two days later. My symptoms have been significantly worse that his), OROPHARYNGEAL PAIN (The patient had very painful swollen glands in her throat/sore throat), LOWER RESPIRATORY TRACT CONGESTION (The next day the patient got head and chest congestion. Felt like I had bronchitis), COUGH (I was coughing) and LYMPHADENOPATHY (Painful Swollen glands) in a 63-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. AU3919B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Patient had no known co-morbidities.     On 11-Oct-2023, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced LOWER RESPIRATORY TRACT CONGESTION (The next day the patient got head and chest congestion. Felt like I had bronchitis), COUGH (I was coughing), LYMPHADENOPATHY (Painful Swollen glands) and INJECTION SITE PAIN (Patient reports that she had a sore left arm at the site of the injection). On 18-Oct-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced COVID-19 (I developed symptoms, testing positive two days later. My symptoms have been significantly worse that his). On 20-Oct-2023, the patient experienced OROPHARYNGEAL PAIN (The patient had very painful swollen glands in her throat/sore throat). At the time of the report, COVID-19 (I developed symptoms, testing positive two days later. My symptoms have been significantly worse that his) and COUGH (I was coughing) outcome was unknown and OROPHARYNGEAL PAIN (The patient had very painful swollen glands in her throat/sore throat), LOWER RESPIRATORY TRACT CONGESTION (The next day the patient got head and chest congestion. Felt like I had bronchitis), LYMPHADENOPATHY (Painful Swollen glands) and INJECTION SITE PAIN (Patient reports that she had a sore left arm at the site of the injection) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2023, SARS-CoV-2 test: Positive.     For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Patient received first Moderna Covid-19 vaccine on April 10, 2021, with lot number 040B21A, received in left arm.  Patient received second Moderna Covid-19 vaccine May 8, 2021, lot number 025C21A, received in left arm.  Patient received third Moderna vaccine lot number 027H21B December 6, 2021, received in left arm.  Patient received fourth Moderna on April 22, 2022, lot number 056M21A, received in left arm. Patient received fifth Moderna vaccine on September 12, 2022, lot number A57144B, received in left arm. For all doses expiration date was not known and no adverse reactions were reported. With sixth dose, patient reported that she had a sore left arm at the site of the injection. She caught COVID-19, had very painful swollen glands in her throat. The next day she got head and chest congestion. Felt like she had bronchitis. She was coughing and had a sore throat. By Oct 21, 2023, the congestion was better. Patient attributed congestion to having stayed in bed for the day on Oct 20, 2023, with a warm compress on her chest. Treatment information was not reported.   This case was linked to MOD-2023-746911 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Oct-2023: Live follow-up received and added references. On 24-Oct-2023: Live follow-up received and added new events of oropharyngeal pain, injection site pain, Bronchial congestion, coughing, updated narrative.